KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Enterprise Value: 2010-2024

Historic Enterprise Value for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $4.9 million.

  • TherapeuticsMD's Enterprise Value fell 62.21% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.5 million, marking a year-over-year decrease of 5877.49%. This contributed to the annual value of $4.9 million for FY2024, which is 75.04% down from last year.
  • Latest data reveals that TherapeuticsMD reported Enterprise Value of $4.9 million as of FY2024, which was down 75.04% from $19.5 million recorded in FY2023.
  • TherapeuticsMD's Enterprise Value's 5-year high stood at $249.6 million during FY2020, with a 5-year trough of -$7.6 million in FY2022.
  • Over the past 3 years, TherapeuticsMD's median Enterprise Value value was $4.9 million (recorded in 2024), while the average stood at $5.6 million.
  • In the last 5 years, TherapeuticsMD's Enterprise Value tumbled by 108.87% in 2022 and then spiked by 354.61% in 2023.
  • Yearly analysis of 5 years shows TherapeuticsMD's Enterprise Value stood at $249.6 million in 2020, then tumbled by 65.49% to $86.2 million in 2021, then crashed by 108.87% to -$7.6 million in 2022, then skyrocketed by 354.61% to $19.5 million in 2023, then plummeted by 75.04% to $4.9 million in 2024.